RecruitingPhase 3NCT07743450
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Sponsor: Ascletis Pharma (China) Co., Limited
Jersey City, NJ · +83 more sites
1 recruiting obesity studies with a site in Jersey City, NJ.
Sponsor: Ascletis Pharma (China) Co., Limited
Jersey City, NJ · +83 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.